Sentinel node biopsy in breast cancer

European Journal of Surgical Oncology

Volumn 27, Issue 1, 2001, Pages 4-8

  Clarke, D ^a   Mansel, R ^a  

^a University Department of Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; NANOCOLL TC 99M; RADIOPHARMACEUTICAL AGENT;

AXILLA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; FROZEN SHOULDER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INJECTION SITE; LEARNING; LYMPHADENECTOMY; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MORBIDITY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOACTIVITY; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

EID: 0035093664     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.1053     Document Type: Editorial

References (53)

1. Number of lymph nodes examined and their prognosis of breast carcinoma
2. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma
3. Relation of tumour size, lymph node status, and survival in 24 740 breast cancer cases
4. Incidence and predictors of axillary metastasisin TI carcinoma of the breast
5. Risk of lymphoedema following the treatment of breast cancer
6. Prospective, randomised controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer
7. The psychological morbidity of breast cancer-related arm swelling: Psychological morbidity of lymphoedema
8. Randomised controlled trial of effects of early discharge after surgery for breast cancer
9. Postmastectomy seromas and wound drainage
10. Assessment of morbidity from complete axillary dissection
11. Clinical evaluation of axillary lymph nodes compared to surgical and pathological findings
12. Assessment of axillary lymph node status
13. Significance of lymph nodes visualised by the mammographic axillary view
14. Ultrasound detection of axillary lymph node metastases in breast cancer
15. Computed tomographic demonstration of lymph node metastases in patients with recurrent breast cancer
16. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging
17. Prediction of axillary metastases in breast cancer by lymphoscintigraphy
18. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: A prospective study
19. Breast cancer staging using technitium-99m sestamibi and indium-III pentetriotide single-photon emission tomography
20. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabelled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose
21. Impact of axillary lymph node dissection on the therapy of breast cancer patients
22. Staging and treatment of clinically occult breast cancer
23. Axillary lymph nodes and breast cancer: A Review
24. An approach for the treatment of penile carcinoma
25. Observations on a "Sentinel Node" in cancer of the parotid
26. Technical details of intraoperative lymphatic mapping for early stage melanoma
27. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
28. Surgical resection and radiolocalisation of the sentinel node in breast cancer using a gamma probe
29. Sentinel node biopsy in breast cancer; initial experience at Memorial Sloan-Kettering Cancer Center
30. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
31. Mammary lymphoscintigraphy in breast cancer
32. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
33. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
34. Sentinel lymph node in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
35. The sentinel node in breast cancer
36. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
37. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
38. Can sentinel node biopsy avoid axillary dissection in clinically node negative breast cancer patients?
39. Sentinel node biopsy in 70 unselected patients with breast cancer: Increased feasibility by using 10mCi radiocolloid in combination with a blue dye tracer
40. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer
41. Technique of selected resection of radiolabelled lymph nodes in breast cancer
42. Lessons learned from 500 cases of lymphatic mapping for breast cancer
43. Intradermal blue dye to identify the sentinel lymph node in breast cancer
44. A method to evaluate intra-operative gamma probes for sentinel lymph node localisation
45. Accuracy of intraoperative frozen-section analysis of axillary nodes
46. Improved axillary staging of breast cancer with sentinel lymphadenectomy
47. Importance of tumour cells in axillary node sinus margins ("clandestine" metastasis) discovered by serial sectioning in operable breast cancer
48. The immunocytochemical detection of axillary micrometastasis in breast cancer
49. The detection of breast cancer micrometastasis in axillary lymph nodes by means of reverse transcriptase polymerase chain reaction
50. Detection and significance of occult axillary node metastasis in patients with invasive breast cancer
51. Prognostic importance of occult axillary lymph node micrometastasis from breast cancer
52. See one, do twenty five, teach one. The implementation of sentinel node dissection in breast cancer
53. Implementation of new surgical technology: Outcome measures for lymphatic mapping of breast carcinoma